Collegium Pharmaceutical Inc (COLL)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	48,155	9,016	-11,161	-29,359	-25,002	-42,837	-35,248	42,786	71,517	103,509	106,749	41,964	26,752	17,593	198	-12,572	-22,722	-11,435	-21,828	-30,176
Revenue (ttm)	US$ in thousands	459,924	438,505	430,531	422,636	400,720	314,280	280,041	251,774	255,854	301,783	299,168	291,446	281,134	286,592	361,135	441,180	518,290	515,321	504,149	494,269
Net profit margin		10.47%	2.06%	-2.59%	-6.95%	-6.24%	-13.63%	-12.59%	16.99%	27.95%	34.30%	35.68%	14.40%	9.52%	6.14%	0.05%	-2.85%	-4.38%	-2.22%	-4.33%	-6.11%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $48,155K ÷ $459,924K
= 10.47%

The net profit margin of Collegium Pharmaceutical Inc has shown fluctuations over the past eight quarters, ranging from a low of -11.84% in Q3 2022 to a high of 8.50% in Q4 2023. Negative margins were recorded in Q2 and Q1 2023, indicating losses during those periods. The company experienced significant improvement in profitability in Q4 2023 compared to previous quarters. Overall, Collegium Pharmaceutical Inc's net profit margin seems to be volatile, with a mixture of positive and negative results in recent quarters. Further analysis of the company's financial performance and underlying factors affecting profitability would be necessary to understand the trend in more detail.